Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
QUICK ABSORPTION:Oral Dissolving Film (ODF) technology ensures rapid absorption, delivering nutrients directly to your system for faster results
So far, beverage giants have downplayed the effect of GLP-1 drugs on their portfolios: pointing to the work theyve already done in building up low and no calorie options over the last couple of decades
In Phase 3 trials, vomiting affected up to 25.3% of people taking retatrutide, compared with 4.8% on placebo
As oral GLP-1s launch, clear education around side effects, expectations and ongoing support will be essential to building confidence
ethics approval is pending and the study is fully funded from corporate resources
However, because retatrutide remains investigational, its benefits must be interpreted alongside its evolving safety profile, dose-related side effects, and the need for ongoing clinical monitoring
